CLINICAL SKILLS » DRUG-ELUTING

Low Dose DCB Showed No Statistically Significant Difference in Patency versus Higher Dose DCB

Learn about the world’s first head-to-head prospective, randomized (1:1) controlled trial comparing the lower dose paclitaxel Ranger DCB (2 μg/mm2) to the higher dose paclitaxel IN.PACT DCB (3.5 μg/mm2).

Download Data Sheet (PDF)

Perspectives on COMPARE-1

Resources

All Resources (-)

  • COMPARE-1 Clinical Trial Overview

    PDF( 351.0 KB )

    Protocol pre-specified interim analysis of first 150 patients (COMPARE pilot) after 12-months of follow-up presented at LINC 2018*

    *Results from the 150 patients from the pilot phase. Overall trial will enroll up to 414 patients.

Top